Pfizer launches antifungal drug Cresemba in Spain, Basilea looks at $427 million
Basilea Pharmaceutica said Thursday its licensing partner Pfizer recently launched the antifungal drug Cresemba (isavuconazole) in Spain. Pfizer is now commercializing…
Pharmaceuticals, Biotechnology and Life Sciences
Basilea Pharmaceutica said Thursday its licensing partner Pfizer recently launched the antifungal drug Cresemba (isavuconazole) in Spain. Pfizer is now commercializing…
TiGenix has further strengthened its IP protection around the company’s lead product Cx601, intended for the treatment of complex perianal fistulas…
Pharmapack Europe 2018 today announced the comprehensive event programme for Europe’s dedicated pharmaceutical packaging and drug delivery conference and exhibition…
Actelion said on Tuesday that, by decision dated October 25, 2017, the Cantonal Court of the Canton of Basel-Landschaft cancelled all…
Novartis said on Tuesday that it has submitted a supplemental Biologics License Application (sBLA) to the US Food and Drug…
Mereo BioPharma has made a deal with AstraZeneca for an exclusive license, including an option to acquire, AZD9668, an oral inhibitor…
Hemogenyx Pharmaceuticals has picked LakePharma as its service provider for the development and manufacturing of Hemogenyx’s lead product, CDX bi-specific…
Novartis said on Monday that it wants to buy Advanced Accelerator Applications (AAA), a radiopharmaceutical company that owns and sells…
Novartis division Sandoz has gotten acceptance for its biosimilar to Amgen’s Neulasta by the European Medicines Agency (EMA) for regulatory…
The largest Russian biotechnology company BIOCAD plans to enter the European market with oncological and autoimmune medicines. So far, there…